(Reuters) – Sage Therapeutics said on Monday that its board has unanimously rejected the takeover offer it received from Biogen and added that its board of directors has initiated a process to explore strategic alternatives.
(Reporting by Sneha S K; Editing by Tasim Zahid)
Comments